In a murine orthotopic model of head and neck SCC, inhibition of mTOR with rapamycin can diminish lymphangiogenesis in the primary tumors and prevent the dissemination of cancer cells to cervical LNs, thereby prolonging animal survival [161]. The gene discussed is MTOR; the disease is cancer.